Growth Metrics

ClearPoint Neuro (CLPT) Gains from Sales and Divestitures (2018 - 2026)

ClearPoint Neuro's Gains from Sales and Divestitures history spans 6 years, with the latest figure at $620493.0 for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures rose 129.24% to $620493.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $620493.0, a 129.24% increase, with the full-year FY2025 number at $620493.0, up 129.24% from a year prior.
  • Gains from Sales and Divestitures hit $620493.0 in Q4 2025 for ClearPoint Neuro, up from $617218.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for CLPT hit a ceiling of $2.0 million in Q3 2021 and a floor of $129434.0 in Q2 2025.
  • Historically, Gains from Sales and Divestitures has averaged $857651.4 across 3 years, with a median of $618855.5 in 2025.
  • Biggest five-year swings in Gains from Sales and Divestitures: soared 271.96% in 2021 and later skyrocketed 129.24% in 2025.
  • Tracing CLPT's Gains from Sales and Divestitures over 3 years: stood at $2.0 million in 2021, then plummeted by 86.62% to $270673.0 in 2024, then skyrocketed by 129.24% to $620493.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for CLPT at $620493.0 in Q4 2025, $617218.0 in Q3 2025, and $129434.0 in Q2 2025.